Dawei Tian
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Cancer, Lipids, and Metabolism 3
-
- Epigenetics and DNA Methylation 4
- Circular RNAs in diseases 4
-
- Bladder and Urothelial Cancer Treatments 19
- Urinary and Genital Oncology Studies 9
-
- Renal cell carcinoma treatment 4
- Journals
- OncoTargets and Therapy (3 papers)Journal of Clinical Oncology (3 papers)Medicine (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Dawei Tian
36 papers receiving 339 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 114
- Oncology 73
- Molecular Biology 178
- Urology 16
- Surgery 103
Countries citing papers authored by Dawei Tian
This map shows the geographic impact of Dawei Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Tian more than expected).
Fields of papers citing papers by Dawei Tian
This network shows the impact of papers produced by Dawei Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Tian. The network helps show where Dawei Tian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dawei Tian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 27 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 2 | |
| 8 | 2021 | 6 | |
| 9 | 2020 | 4 | |
| 10 | 2020 | 36 | |
| 11 | Protein kinase TTK promotes proliferation and migration and mediates epithelial-mesenchymal transition in human bladder cancer cells. | 2018 | 11 |
| 12 | 2017 | 1 | |
| 13 | 2017 | 10 | |
| 14 | 2016 | 7 | |
| 15 | 2016 | 7 | |
| 16 | 2016 | 34 | |
| 17 | 2015 | 5 | |
| 18 | 2015 | 29 | |
| 19 | 2015 | 7 | |
| 20 | 2015 | 9 |
About Dawei Tian
Dawei Tian is a scholar working on Urology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Rheumatology, having authored 40 papers that have together received 346 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (19 papers), Urinary and Genital Oncology Studies (9 papers), Renal cell carcinoma treatment (4 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Epigenetics and DNA Methylation (4 papers), Circular RNAs in diseases (4 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (114 citations), Oncology (73 citations), Molecular Biology (178 citations), Urology (16 citations) and Surgery (103 citations). Dawei Tian has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Changli Wu, Zhouliang Wu, Hailong Hu, Wanqin Xie, Linguo Xie, Chong Shen, Ruifa Han, Liming Jiang, Yujie Wang and Feiran Chen. Their work appears in journals such as OncoTargets and Therapy, Journal of Clinical Oncology, Medicine, Carcinogenesis and Environmental Pollution.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.